Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H34N2O5.ClH |
Molecular Weight | 491.019 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=C(OC)C=C2[C@@H](CNCCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1
InChI
InChIKey=MIIIKWNQFDQJGS-VEIFNGETSA-N
InChI=1S/C26H34N2O5.ClH/c1-30-22-11-17-6-9-28(26(29)14-18(17)12-23(22)31-2)8-5-7-27-16-20-10-19-13-24(32-3)25(33-4)15-21(19)20;/h11-13,15,20,27H,5-10,14,16H2,1-4H3;1H/t20-;/m1./s1
Molecular Formula | C26H34N2O5 |
Molecular Weight | 454.5586 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9728900Curator's Comment: description was created based on several sources, including
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206143Orig1s000PharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/26202095
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9728900
Curator's Comment: description was created based on several sources, including
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206143Orig1s000PharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/26202095
N-Demethyl Ivabradine Hydrochloride is an active metabolite of Ivabradine. Ivabradine protects myocardium in acute ischemic conditions and has favorably sustained remo- deling properties in the long term. N-dealkylated metabolite has also been shown to decrease heart rate in pre-clinical studies when administered to dogs
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9728900
Unpublished studies showed that this metabolite (N-DEMETHYL IVABRADINE) reduced heart rate in conscious dogs by decreasing sinus node activity after oral and intravenous administrations,
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:11:14 GMT 2023
by
admin
on
Sat Dec 16 19:11:14 GMT 2023
|
Record UNII |
A9VZ3925C8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
66672699
Created by
admin on Sat Dec 16 19:11:14 GMT 2023 , Edited by admin on Sat Dec 16 19:11:14 GMT 2023
|
PRIMARY | PUBCHEM | ||
|
DTXSID40735561
Created by
admin on Sat Dec 16 19:11:14 GMT 2023 , Edited by admin on Sat Dec 16 19:11:14 GMT 2023
|
PRIMARY | |||
|
A9VZ3925C8
Created by
admin on Sat Dec 16 19:11:14 GMT 2023 , Edited by admin on Sat Dec 16 19:11:14 GMT 2023
|
PRIMARY | |||
|
1246638-08-3
Created by
admin on Sat Dec 16 19:11:14 GMT 2023 , Edited by admin on Sat Dec 16 19:11:14 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|